Browsing by Ajou Author

강, 석윤(Kang, Seok Yun) Currently indexed
[School of Medicine / Graduate School of Medicine] - [Hematology-Oncology]

Author IDs

ORCID
-
WOS
-
SCOPUS
-

Showing results 1 to 20 of 90

This table browses all dspace content
Pub YearTitleAuthor(s)
2021Significance of descriptive symptoms and signs and clinical parameters as predictors of neuropathic cancer pain강석윤
2021Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data강석윤, 김태환, 신승수, 안미선, 이현우, 조헌도, 최용원, 최진혁
2021Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁
2021Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO) (KCSG BR 10-13)강석윤
2021Corrigendum to ‘Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer’, [Eur J Canc 51 (2015) 482–488]강석윤
2021Implications of tamoxifen resistance in palbociclib efficacy for patients with hormone receptor-positive, her2-negative metastatic breast cancer: Subgroup analyses of kcsg-br15-10 (youngpearl)강석윤
2021Clinicopathological and Molecular Analysis of 45 Cases of Pure Mucinous Breast Cancer강석윤, 김장희, 김태규, 노진, 안미선, 임현이, 정용식, 최진혁
2021Characterizing the anticancer treatment trajectory and pattern in patients receiving chemotherapy for cancer using harmonized observational databases: Retrospective study강석윤, 박래웅
2021Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)강석윤
2020Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)강석윤
2020Combination versus single-agent as palliative chemotherapy for gastric cancer강석윤, 박준성, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁
2020Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial강석윤
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤, 안미선, 이현우
2019Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial강석윤
2019EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment강석윤
2019Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?강석윤, 안미선, 이현우, 최용원, 최진혁
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤
2019A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)강석윤
2019Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)강석윤
2019Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression강석윤, 김장희, 박태준, 최용원
1 2 3 4 5

Browse